Spotlight on TAP and its vital role in antigen presentation and cross-presentation is a research paper published in Molecular Immunology (2021). On theSindex it has a DataRank of 0.681. It has been cited 93 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.681
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AI123284
National Institutes of Health
Grant: AI127658
National Institutes of Health
Grant: AI154294
National Institutes of Health
Grant: DK111862
NIAID NIH HHS
Grant: R21 AI159772
NIAID NIH HHS
Grant: R21 AI154294
NIAID NIH HHS
Grant: R01 AI127658
NIAID NIH HHS
Grant: R01 AI123284
NIAID NIH HHS
Grant: R01 AI170897
NIDDK NIH HHS
Grant: R01 DK111862
NIAID NIH HHS
Grant: R01 AI170832
National Institutes of Health
Grant: 7R01AI123284-02
Non-Canonical Cross-presentation in Dendritic Cells Upon TAP Blockade
National Institutes of Health
Grant: 5R01AI127658-05
Novel vita-vaccine formula combines safety of dead and efficacy of live vaccines
National Institutes of Health
Grant: 5R01DK111862-02
Role of apoptosis in the intestinal epithelium during homeostasis and disease
Burroughs Wellcome Fund
Influential Citations
2
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 1 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 1 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 1 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 2 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 2 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 3 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 3 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 4 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 4 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 5 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 5 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 6 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 6 of The integration of single-cell and bulk RNA-seq atlas reveals ERS-mediated acinar cell damage in acute pancreatitis
Additional file 2 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 3 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 3 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Additional file 2 of Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy